Results 231 to 240 of about 51,409 (257)
Some of the next articles are maybe not open access.

Related searches:

Crystallization of diphtheria toxin

Journal of Molecular Biology, 1991
Two new crystal forms (forms III and IV) have been grown of diphtheria toxin (DT), which kills susceptible cells by catalyzing the ADP-ribosylation of elongation factor 2, thereby stopping protein synthesis. Forms III and IV diffract to 2.3 A and 2.7 A resolution, respectively.
Seunghyon Choe   +3 more
openaire   +3 more sources

On the formation of diphtheria toxin in saliva byC. diphtheriae

Antonie van Leeuwenhoek, 1953
1. The iron contents of a number of saliva samples were determined. The iron contents found varied from 0.10–0.61 γ per g of saliva, while in some cases the iron quantity present was so small that it could not be determined. 2. These iron contents are of the same quantitative order as the concentrations of this element in the various ...
L. Smith, A. Tasman
openaire   +2 more sources

Diphtheria Toxin and the Diphtheria-Toxin Receptor

2000
The discovery of diphtheria toxin from culture medium of Corynehacterium diphtheriae was one of the greatest discoveries in medical history. Since this epoch-making change in medicine, diphtheria toxin has been studied, first to prevent disease and later to understand the pathogenic mechanism at the molecular level. A number of important discoveries in
K. D. Sharma, T. Umata, Eisuke Mekada
openaire   +2 more sources

Anaphylaxis to Diphtheria Toxin

The Journal of Immunology, 1932
Abstract Previously reported experiments (1, 2, 3) on anaphylaxis apparently due to the toxin or toxoid antigen were made upon actively sensitized (antitoxic immune) animals. The results had indicated that while other diphtheria antigens participated to some extent, the major part of the anaphylaxis could be assigned to the toxin or ...
John Y Sugg   +2 more
openaire   +1 more source

Diphtheria toxin

2015
Diphtheria toxin (DT) is one of the most extensively studied bacterial toxins with intracellular action. It is produced by toxigenic strains of Corynebacterium diphtheriae and is responsible for the symptoms of diphtheria. The toxin was isolated in 1888. A vaccine was developed in 1923.
Daniel Gillet, Julien Barbier
openaire   +2 more sources

The crystal structure of diphtheria toxin

Nature, 1992
The crystal structure of the diphtheria toxin dimer at 2.5 A resolution reveals a Y-shaped molecule of three domains. The catalytic domain, called fragment A, is of the alpha + beta type. Fragment B actually consists of two domains. The transmembrane domain consists of nine alpha-helices, two pairs of which are unusually apolar and may participate in ...
Gary Fujii   +6 more
openaire   +3 more sources

Diphtheria Toxin Fusion Proteins

1998
Two different approaches have been undertaken to develop targeted biomolecules for therapeutics. The first was the construction of immunotoxins consisting of monoclonal antibodies chemically linked through a disulfide bond to a plant or bacterial toxin or radionuclide.
James G. Krueger   +4 more
openaire   +3 more sources

Diphtheria toxin-receptor interaction: A polyphosphate-insensitive diphtheria toxin-binding domain

Biochemical and Biophysical Research Communications, 1982
Abstract Inositol hexaphosphate, and other polyphosphates, inhibit diphtheria toxin-mediated cytotoxicity by binding to the toxin at a highly cationic site called the P site and preventing toxin binding to cell surface receptors. The binding of diphtheria toxin to a solubilized cell surface glycoprotein (150,000 daltons) is also inhibited by these ...
Lisa L. Ross, Leon Eidels, David A. Hart
openaire   +3 more sources

Home - About - Disclaimer - Privacy